Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Sep;92(3):1387–1393. doi: 10.1172/JCI116713

The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.

M Simon 1, E Girbal 1, M Sebbag 1, V Gomès-Daudrix 1, C Vincent 1, G Salama 1, G Serre 1
PMCID: PMC288281  PMID: 7690781

Abstract

In rheumatoid arthritis (RA), the high diagnostic value of serum antibodies to the stratum corneum of rat esophagus epithelium has been widely reported. These so-called "antikeratin antibodies," detected by indirect immunofluorescence, were found to be autoantibodies since they also labeled human epidermis. Despite their name, the actual target of these autoantibodies was not known. In this study, a 40-kD protein (designated as 40K), extracted from human epidermis and specifically immunodetected by 75% of RA sera, was purified and identified as a neutral/acidic isoform of basic filaggrin, a cytokeratin filament-aggregating protein, by peptide mapping studies and by the following evidences: (a) mAbs specific for filaggrin reacted with the 40K protein; (b) the autoantibodies, affinity-purified from RA sera on the 40K protein, immunodetected purified filaggrin; (c) the reactivity of RA sera to the 40K protein was abolished after immunoadsorption with purified filaggrin; (d) the 40K protein and filaggrin had similar amino acid compositions. Furthermore, autoantibodies against the 40K protein and the so-called "antikeratin antibodies" were shown, by immunoadsorption experiments, to be largely the same. The identification of filaggrin as a RA-specific autoantigen could contribute to the understanding of the pathogenesis of this disease and, ultimately, to the development of methods for preventing the autoimmune response.

Full text

PDF
1387

Images in this article

1388Image
on p.1388
1388Image
on p.1388
1388Image
on p.1388
1388Image
on p.1388
1388Image
on p.1388
1389Image
on p.1389
1389Image
on p.1389
1389Image
on p.1389
1389Image
on p.1389
1389Image
on p.1389
1389Image
on p.1389
1390Image
on p.1390
1390Image
on p.1390
1390Image
on p.1390
1390Image
on p.1390
1391Image
on p.1391
1391Image
on p.1391
1391Image
on p.1391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  2. Baboonian C., Venables P. J., Williams D. G., Williams R. O., Maini R. N. Cross reaction of antibodies to a glycine/alanine repeat sequence of Epstein-Barr virus nuclear antigen-1 with collagen, cytokeratin, and actin. Ann Rheum Dis. 1991 Nov;50(11):772–775. doi: 10.1136/ard.50.11.772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brendel V., Dohlman J., Blaisdell B. E., Karlin S. Very long charge runs in systemic lupus erythematosus-associated autoantigens. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1536–1540. doi: 10.1073/pnas.88.4.1536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cleveland D. W., Fischer S. G., Kirschner M. W., Laemmli U. K. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem. 1977 Feb 10;252(3):1102–1106. [PubMed] [Google Scholar]
  5. Dale B. A., Gown A. M., Fleckman P., Kimball J. R., Resing K. A. Characterization of two monoclonal antibodies to human epidermal keratohyalin: reactivity with filaggrin and related proteins. J Invest Dermatol. 1987 Mar;88(3):306–313. doi: 10.1111/1523-1747.ep12466185. [DOI] [PubMed] [Google Scholar]
  6. Dale B. A., Holbrook K. A., Steinert P. M. Assembly of stratum corneum basic protein and keratin filaments in macrofibrils. Nature. 1978 Dec 14;276(5689):729–731. doi: 10.1038/276729a0. [DOI] [PubMed] [Google Scholar]
  7. Gan S. Q., McBride O. W., Idler W. W., Markova N., Steinert P. M. Organization, structure, and polymorphisms of the human profilaggrin gene. Biochemistry. 1990 Oct 9;29(40):9432–9440. doi: 10.1021/bi00492a018. [DOI] [PubMed] [Google Scholar]
  8. Hajiroussou V. J., Skingle J., Gillett A. P., Webley M. Significance of antikeratin antibodies in rheumatoid arthritis. J Rheumatol. 1985 Feb;12(1):57–59. [PubMed] [Google Scholar]
  9. Harding C. R., Scott I. R. Histidine-rich proteins (filaggrins): structural and functional heterogeneity during epidermal differentiation. J Mol Biol. 1983 Nov 5;170(3):651–673. doi: 10.1016/s0022-2836(83)80126-0. [DOI] [PubMed] [Google Scholar]
  10. Harris E. D., Jr Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med. 1990 May 3;322(18):1277–1289. doi: 10.1056/NEJM199005033221805. [DOI] [PubMed] [Google Scholar]
  11. Hermann E., Lohse A. W., Van der Zee R., Van Eden W., Mayet W. J., Probst P., Poralla T., Meyer zum Büschenfelde K. H., Fleischer B. Synovial fluid-derived Yersinia-reactive T cells responding to human 65-kDa heat-shock protein and heat-stressed antigen-presenting cells. Eur J Immunol. 1991 Sep;21(9):2139–2143. doi: 10.1002/eji.1830210923. [DOI] [PubMed] [Google Scholar]
  12. Hoet R. M., Boerbooms A. M., Arends M., Ruiter D. J., van Venrooij W. J. Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin. Ann Rheum Dis. 1991 Sep;50(9):611–618. doi: 10.1136/ard.50.9.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Johnson G. D., Carvalho A., Holborow E. J., Goddard D. H., Russell G. Antiperinuclear factor and keratin antibodies in rheumatoid arthritis. Ann Rheum Dis. 1981 Jun;40(3):263–266. doi: 10.1136/ard.40.3.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kouri T., Petersen J., Rhodes G., Aho K., Palosuo T., Heliövaara M., Isomäki H., von Essen R., Vaughan J. H. Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera. J Rheumatol. 1990 Nov;17(11):1442–1449. [PubMed] [Google Scholar]
  15. Kurki P., Aho K., Palosuo T., Heliövaara M. Immunopathology of rheumatoid arthritis. Antikeratin antibodies precede the clinical disease. Arthritis Rheum. 1992 Aug;35(8):914–917. doi: 10.1002/art.1780350810. [DOI] [PubMed] [Google Scholar]
  16. Lonsdale-Eccles J. D., Haugen J. A., Dale B. A. A phosphorylated keratohyalin-derived precursor of epidermal stratum corneum basic protein. J Biol Chem. 1980 Mar 25;255(6):2235–2238. [PubMed] [Google Scholar]
  17. Lonsdale-Eccles J. D., Teller D. C., Dale B. A. Characterization of a phosphorylated form of the intermediate filament-aggregating protein filaggrin. Biochemistry. 1982 Nov 9;21(23):5940–5948. doi: 10.1021/bi00266a033. [DOI] [PubMed] [Google Scholar]
  18. Lynley A. M., Dale B. A. The characterization of human epidermal filaggrin. A histidine-rich, keratin filament-aggregating protein. Biochim Biophys Acta. 1983 Apr 14;744(1):28–35. doi: 10.1016/0167-4838(83)90336-9. [DOI] [PubMed] [Google Scholar]
  19. McKinley-Grant L. J., Idler W. W., Bernstein I. A., Parry D. A., Cannizzaro L., Croce C. M., Huebner K., Lessin S. R., Steinert P. M. Characterization of a cDNA clone encoding human filaggrin and localization of the gene to chromosome region 1q21. Proc Natl Acad Sci U S A. 1989 Jul;86(13):4848–4852. doi: 10.1073/pnas.86.13.4848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Miossec P., Youinou P., Le Goff P., Moineau M. P. Clinical relevance of antikeratin antibodies in rheumatoid arthritis. Clin Rheumatol. 1982 Sep;1(3):185–189. doi: 10.1007/BF02042772. [DOI] [PubMed] [Google Scholar]
  21. NIENHUIS R. L., MANDEMA E. A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR. Ann Rheum Dis. 1964 Jul;23:302–305. doi: 10.1136/ard.23.4.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ordeig J., Guardia J. Diagnostic value of antikeratin antibodies in rheumatoid arthritis. J Rheumatol. 1984 Oct;11(5):602–604. [PubMed] [Google Scholar]
  23. Paimela L., Gripenberg M., Kurki P., Leirisalo-Repo M. Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis. 1992 Jun;51(6):743–746. doi: 10.1136/ard.51.6.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Quismorio F. P., Jr, Kaufman R. L., Beardmore T., Mongan E. S. Reactivity of serum antibodies to the keratin layer of rat esophagus in patients with rheumatoid arthritis. Arthritis Rheum. 1983 Apr;26(4):494–499. doi: 10.1002/art.1780260407. [DOI] [PubMed] [Google Scholar]
  25. Reano A., Sarret Y., Thivolet J. GP37 is different from filaggrin. J Invest Dermatol. 1990 Jul;95(1):70–73. doi: 10.1111/1523-1747.ep12873966. [DOI] [PubMed] [Google Scholar]
  26. Serre G., Vincent C., Fournié B., Lapeyre F., Soleilhavoup J. P., Fournié A. Anticorps anti-stratum corneum d'oesophage de rat, auto-anticorps anti-kératines épidermiques et anti-épiderme dans la polyarthrite rhumatoïde et différentes affections rhumatologiques. Intérêt diagnostique, aspects fondamentaux. Rev Rhum Mal Osteoartic. 1986 Nov;53(11):607–614. [PubMed] [Google Scholar]
  27. Serre G., Vincent C., Viraben R., Soleilhavoup J. P. Natural IgM and IgG autoantibodies to epidermal keratins in normal human sera. I: ELISA-titration, immunofluorescence study. J Invest Dermatol. 1987 Jan;88(1):21–27. doi: 10.1111/1523-1747.ep12464810. [DOI] [PubMed] [Google Scholar]
  28. Shmerling R. H., Delbanco T. L. The rheumatoid factor: an analysis of clinical utility. Am J Med. 1991 Nov;91(5):528–534. doi: 10.1016/0002-9343(91)90190-9. [DOI] [PubMed] [Google Scholar]
  29. Simon M., Spahr P. F., Dainous F. The proteins associated with the soluble form of p36, the main target of the src oncogene product in chicken fibroblasts, are glycolytic enzymes. Biochem Cell Biol. 1989 Oct;67(10):740–748. doi: 10.1139/o89-111. [DOI] [PubMed] [Google Scholar]
  30. Sondag-Tschroots I. R., Aaij C., Smit J. W., Feltkamp T. E. The antiperinuclear factor. 1. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis. Ann Rheum Dis. 1979 Jun;38(3):248–251. doi: 10.1136/ard.38.3.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Steiner G., Hartmuth K., Skriner K., Maurer-Fogy I., Sinski A., Thalmann E., Hassfeld W., Barta A., Smolen J. S. Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. J Clin Invest. 1992 Sep;90(3):1061–1066. doi: 10.1172/JCI115921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Steinert P. M., Cantieri J. S., Teller D. C., Lonsdale-Eccles J. D., Dale B. A. Characterization of a class of cationic proteins that specifically interact with intermediate filaments. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4097–4101. doi: 10.1073/pnas.78.7.4097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tan E. M. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol. 1989;44:93–151. doi: 10.1016/s0065-2776(08)60641-0. [DOI] [PubMed] [Google Scholar]
  34. Veys E. M., De Keyser F., De Vlam K., Verbruggen G. The antiperinuclear factor. Clin Exp Rheumatol. 1990 Sep-Oct;8(5):429–431. [PubMed] [Google Scholar]
  35. Vincent C., Serre G., Fournié B., Fournié A., Soleilhavoup J. P. Natural IgG to epidermal cytokeratins vs IgG to the stratum corneum of the rat oesophagus epithelium, so-called 'antikeratin antibodies', in rheumatoid arthritis and other rheumatic diseases. J Autoimmun. 1991 Jun;4(3):493–505. doi: 10.1016/0896-8411(91)90161-5. [DOI] [PubMed] [Google Scholar]
  36. Vincent C., Serre G., Lapeyre F., Fournié B., Ayrolles C., Fournié A., Soleilhavoup J. P. High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called 'antikeratin antibodies'. Ann Rheum Dis. 1989 Sep;48(9):712–722. doi: 10.1136/ard.48.9.712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wraith D. C., McDevitt H. O., Steinman L., Acha-Orbea H. T cell recognition as the target for immune intervention in autoimmune disease. Cell. 1989 Jun 2;57(5):709–715. doi: 10.1016/0092-8674(89)90786-1. [DOI] [PubMed] [Google Scholar]
  38. Young B. J., Mallya R. K., Leslie R. D., Clark C. J., Hamblin T. J. Anti-keratin antibodies in rheumatoid arthritis. Br Med J. 1979 Jul 14;2(6182):97–99. doi: 10.1136/bmj.2.6182.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Young R. A. Stress proteins and immunology. Annu Rev Immunol. 1990;8:401–420. doi: 10.1146/annurev.iy.08.040190.002153. [DOI] [PubMed] [Google Scholar]
  40. van Eden W., Thole J. E., van der Zee R., Noordzij A., van Embden J. D., Hensen E. J., Cohen I. R. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature. 1988 Jan 14;331(6152):171–173. doi: 10.1038/331171a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES